The European Medicines Agency has approved Tevimbra (tislelizumab) in combination with chemotherapy for advanced throat and stomach cancers. The approval, based on positive Phase III trial results, ...

After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...

The Down syndrome treatment market in the USA is valued at nearly $250 million, with companies like Aelis Farma, AC Immune, ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

The strain of opioid use disorder (OUD), a chronic neurological disorder characterized by the compulsive, repeated use of ...

Novartis announced today that the European Commission (EC) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of patients with hormone ...

The Biden administration has proposed a new rule that could significantly expand Medicare and Medicaid coverage for obesity ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

The US Food and Drug Administration (FDA) has extended the review period for Soleno Therapeutics’ the New Drug Application ...

AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now ...

Swiss drugmaker Idorsia was trading more than 10% higher by lunchtime on Wednesday. Idorsia earlier announced that it has entered into exclusive negotiations with an undisclosed party for the global ...

Samsung Bioepis has appointed Kyung-Ah Kim as president and CEO, succeeding Christopher Hansung Ko. The leadership change ...